A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder-Reference-Cited by-同舟云学术

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder

Published:2004 Issue:9 Volume:50 Page:2974-2984
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Arnold Lesley M.,Lu Yili,Crofford Leslie J.,Wohlreich Madelaine,Detke Michael J.,Iyengar Smriti,Goldstein David J.,

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference46 articles.

1. THE RELATIONSHIP BETWEEN FIBROMYALGIA AND MAJOR DEPRESSIVE DISORDER

2. The american college of rheumatology 1990 criteria for the classification of fibromyalgia

3. The prevalence and characteristics of fibromyalgia in the general population

4. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis

Cited by 500 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of a Pain Self-Management Intervention Tailored to People With HIV;JAMA Internal Medicine;2024-09-01

2. Pharmacological Treatment of Fibromyalgia Syndrome: A Practice-Based Review;Current Pain and Headache Reports;2024-07-23

3. Emotional Awareness and Expression Therapy vs Cognitive Behavioral Therapy for Chronic Pain in Older Veterans;JAMA Network Open;2024-06-13

4. Transcutaneous Electrical Nerve Stimulation for Fibromyalgia-like Syndrome in Patients with Post-Acute Sequelae of Sars-Cov-2: A Pilot Randomized Clinical Trial;2024-06-03

5. Shared comorbidity of depression, migraine, insomnia, and fibromyalgia in a population-based sample;Journal of Affective Disorders;2024-06